Media Coverage

HemaCare Adds GMPrime Cryopreserved Leukopak to Its GMP Product Portfolio

HemaCare Adds GMPrime Cryopreserved Leukopak to Its GMP Product Portfolio

Pharmaceutical Outsourcing

HemaCare Corporation, a Charles River Laboratories company, has expanded its portfolio of GMP-compliant cellular material with the launch of the GMPrime cryopreserved leukopak. The GMP-compliant cryopreserved leukopak includes a quality assurance (QA)-reviewed Certificate of Analysis, thus adding QA review to HemaCare’s popular research use (HemaPrime) cryopreserved leukopak. HemaCare’s GMPrime leukopaks are cryopreserved following a proprietary cryopreservation process and meet the requirements of the most rigorous quality standards required by regulatory agencies. GMPrime cryopreserved leukopaks extend shelf life and stability and provide researchers and cell therapy developers with the consistency needed in a cellular starting material used for the development and commercialization of next-generation cell and gene therapies.

Read the full article